Title : Synergistic cytotoxicity of iodine-131-anti-CD20 monoclonal antibodies and chemotherapy for treatment of B-cell lymphomas.

Pub. Date : 2000 Jan 1

PMID : 10585592






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Synergistic cytotoxicity of iodine-131-anti-CD20 monoclonal antibodies and chemotherapy for treatment of B-cell lymphomas. Iodine-131 keratin 20 Homo sapiens
2 Preliminary clinical trials suggest that iodine-131 ((131)I)-labeled anti-CD20 monoclonal antibodies (MAbs) are effective single agents for the treatment of relapsed non-Hodgkin"s B-cell lymphomas. Iodine-131 keratin 20 Homo sapiens
3 Thus, combination regimens containing (131)I-labeled anti-CD20 antibodies and nucleoside analogs or topoisomerase inhibitors appear particularly attractive for future clinical trials. Iodine-131 keratin 20 Homo sapiens